Watson Pharmaceuticals: An indicative announcement on the conditions expected to trigger a decline in the price of Watson debt-for-equity swaps

SZSI · Aug 17, 2022 00:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.